GlaxoSmithKline Consumer Healthcare Limited
NSE Symbol GSKCONS
GLAXO SMITHKLINE has declared excellent Results for the Year ended December 2010, compared to the previous 2 years.
Net Sales in Jan-Dec 2010 are : Rs.2306 cr – up by 20.02% Compared to Jan-dec 2009 and by 49.48% compared to 2008.
Total Expenditure in 2010 is Rs.1969 cr – up by 19.15% from 2009 and by 46.16% from 2008.
Profit from operations is Rs.405 cr – up by 22.11% from 2009 and by 65.1% from 2008.
Net profit for 2010 is Rs.300 cr – up by 28.81% from 2009 and by 59.22% from 2008.
Basic EPS on a Face Value of Rs.10 is Rs.71.3 for 2010, against Rs. 55.35 in 2009 and Rs.44.78 in 2008.
Thus, on an annual basis, Glaxo has done excellently in the year 2010 compared to the previous 2 years.
RESULTS TABLE :
| FY JAN-DEC 2010 | |||
| Net Sales | 230612 | 192150 | 154278 |
| DIF %1 | 2306 | 20.02 | 49.48 |
| Other Oprtng Income | 6763 | 6255 | 4952 |
| Incre./Decr.in SIT / WIP | -2980 | -1720 | -4605 |
| Raw Materials | 77834 | 66258 | 63180 |
| traded goods | 11637 | 6523 | - |
| Employees Cost | 22966 | 20070 | 17195 |
| Depreciation | 3971 | 4202 | 4195 |
| Other Expenditure | 83483 | 69936 | 54756 |
| Total Expenditure | 196911 | 165269 | 134721 |
| DIF %2 | 1969 | 19.15 | 46.16 |
| Profit from Operations | 40464 | 33136 | 24509 |
| DIF %3 | 405 | 22.11 | 65.1 |
| Other Income | 4976 | 2677 | 4596 |
| Profit before I & EI | 45440 | 35813 | 29105 |
| Interest | 260 | 427 | 697 |
| Profit after Int. BB EI | 45180 | 35386 | 28408 |
| Profit( before tax | 45180 | 35386 | 28408 |
| Tax Expense | 15195 | 12108 | 9575 |
| Net Profit after tax | 29985 | 23278 | 18833 |
| Net Profit | 29985 | 23278 | 18833 |
| DIF %4 | 300 | 28.81 | 59.22 |
| Face Value (in Rs.) | 10 | 10 | 10 |
| Paid-up Equity | 4206 | 4206 | 4206 |
| Basic EPS | 71.3 | 55.35 | 44.78 |
| Public Shareholding (%) | 56.84 | 56.84 | - |
ANNOUNCEMENTS
TO THE EXCHANGE
02-02-2011 GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2010 as follows: Net Sales of Rs. 230612 lacs for year ending on 31-DEC-2010 against Rs. 192150 lacs for the year ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 29985 lacs for the year ending on 31-DEC-2010 against Rs. 23278 lacs for the year ending on 31-DEC-2009. -
02-02-2011 GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 50776 lacs for quarter ending on 31-DEC-2010 against Rs. 41812 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 5337 lacs for the quarter ending on 31-DEC-2010 against Rs. 3368 lacs for the quarter ending on 31-DEC-2009. -
02-02-2011 Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 02, 2011 has recommended a Dividend at the rate of Rs. 50 per equity share of Rs.10 each (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share to celebrate Golden Jubilee of the Company).
* * * E N D * * *
No comments:
Post a Comment